US Capital Global Securities Launches $7MM Preferred Stock Offering for Dianomi Therapeutics, Inc.

Ads

You May Also Like

Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES

PRESS RELEASE: REGULATED INFORMATION9 October 2018, 07:00 CESTDisclosure of Outstanding Voting Securities Mechelen, Belgium, ...

Curetis Subsidiary Ares Genetics Launches ARES & CO Pharma Partnering Program

Curetis Subsidiary Ares Genetics Launches ARES & CO Pharma Partnering Program Program aims to ...